id: https://openalex.org/W4226236384
doi: https://doi.org/10.1056/nejmoa2118542
title: Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19
publication_date: '2022-02-16'
publication_year: 2022
cited_by_count: 2106
citation_percentile: 0.999952
pagerank: 2.5353607273927495e-06
authorships:
- author_id: https://openalex.org/A5014348590
  display_name: Jennifer Hammond
  orcid: https://orcid.org/0000-0003-0809-3953
  author_position: first
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, Collegeville, PA, Pfizer, Cambridge, MA
- author_id: https://openalex.org/A5018801440
  display_name: "Heidi Leister\u2010Tebbe"
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, Collegeville, PA, Pfizer, Cambridge, MA
- author_id: https://openalex.org/A5027001370
  display_name: Annie Gardner
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, Cambridge, MA
- author_id: https://openalex.org/A5068803228
  display_name: Paula Abreu
  orcid: https://orcid.org/0000-0003-4871-8532
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, New York
- author_id: https://openalex.org/A5002746489
  display_name: Weihang Bao
  orcid: https://orcid.org/0000-0001-6331-0805
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, New York
- author_id: https://openalex.org/A5064949379
  display_name: Wayne Wisemandle
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, Lake Forest, IL
- author_id: https://openalex.org/A5041720021
  display_name: MaryLynn Baniecki
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Early Clinical Development, Pfizer, Cambridge, MA
- author_id: https://openalex.org/A5018464880
  display_name: Victoria M. Hendrick
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I189718659
    display_name: Pfizer (United Kingdom)
    ror: https://ror.org/04x4v8p40
    country_code: GB
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Medical and Safety, Pfizer, Sandwich, United Kingdom
- author_id: https://openalex.org/A5017481574
  display_name: Bharat Damle
  orcid: https://orcid.org/0000-0002-4615-0122
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, New York
- author_id: https://openalex.org/A5089966401
  display_name: "Jesus Abraham Sim\xF3n Campos"
  orcid: https://orcid.org/0000-0001-9630-7792
  author_position: middle
  institutions: []
  is_corresponding: false
  raw_affiliation_strings:
  - "K\xF6hler and Milstein Research, M\xE9rida, Yucatan, Mexico"
- author_id: https://openalex.org/A5023276611
  display_name: Rienk Pypstra
  orcid: null
  author_position: middle
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, New York
- author_id: https://openalex.org/A5018318533
  display_name: James M. Rusnak
  orcid: null
  author_position: last
  institutions:
  - id: https://openalex.org/I180857899
    display_name: Pfizer (United States)
    ror: https://ror.org/01xdqrp08
    country_code: US
    type: funder
  is_corresponding: false
  raw_affiliation_strings:
  - Global Product Development, Pfizer, Tampa, FL
referenced_works:
- https://openalex.org/W2027484375
- https://openalex.org/W2059707463
- https://openalex.org/W2147472643
- https://openalex.org/W2161572568
- https://openalex.org/W2163761019
- https://openalex.org/W2341244791
- https://openalex.org/W3008028633
- https://openalex.org/W3016067754
- https://openalex.org/W3020646040
- https://openalex.org/W3026764413
- https://openalex.org/W3043192034
- https://openalex.org/W3113178943
- https://openalex.org/W3122877585
- https://openalex.org/W3152572687
- https://openalex.org/W3165479483
- https://openalex.org/W3180445914
- https://openalex.org/W3189646261
- https://openalex.org/W3204153794
- https://openalex.org/W3208080692
- https://openalex.org/W4200303124
- https://openalex.org/W4242589154
primary_topic: SARS-CoV-2 and COVID-19 Research
open_access: true
